SPARCL1 was downregulated in gastrointestinal stromal tumors, which contributed to cell migration and invasion, and SPARCL1 can predict the prognosis of gastrointestinal stromal tumors (P = 0.008) [30]. This evidence concerns the gene SPARCL1 and gastrointestinal stromal tumor.